• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Chimerix, Inc. - Common Stock (NQ: CMRX )

    3.390 -0.090 (-2.59%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Chimerix, Inc. - Common Stock

    < Previous 1 2 3 4 Next >
    A Glimpse Into The Expert Outlook On Chimerix Through 4 Analysts
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings
    Via Benzinga
    Dow Falls 150 Points; Oracle Posts Downbeat Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    CMRX Stock Earnings: Chimerix Misses EPS for Q1 2024
    CMRX stock results show that Chimerix missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Earnings Scheduled For February 29, 2024
    Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
    Via Benzinga
    Preview: Chimerix's Earnings
    Via Benzinga
    Earnings Outlook For Chimerix
    Via Benzinga
    Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?
    Chimerix plans to submit an NDA for dordaviprone to treat H3 K27M-mutant glioma, with potential U.S. FDA approval targeted for late 2025. 
    Via Benzinga
    Exposures Product Safety
    Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    CMRX Stock Earnings: Chimerix Meets EPS, Beats Revenue for Q2 2024
    CMRX stock results show that Chimerix met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
    The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    4 Analysts Have This to Say About Chimerix
    Via Benzinga
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    Chimerix Earnings Preview
    Via Benzinga
    CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
    CMRX stock may seem like a high-risk, high-potential play, but it makes sense why the market has bid down this biotech. 
    Via InvestorPlace
    7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
    Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns. 
    Via InvestorPlace
    7 Small-Cap Stocks to Buy Before the Breakout
    If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy. 
    Via InvestorPlace
    Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
    With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look. 
    Via InvestorPlace
    7 Deeply Undervalued Growth Stocks to Buy in June
    Investors may see significant rewards betting on these best undervalued growth stocks for June. 
    Via InvestorPlace
    Looking Into Chimerix's Return On Capital Employed
    Via Benzinga
    Chimerix's Earnings Outlook
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
    Via Benzinga
    7 Thrilling Biotech Stocks for Aggressive Investors to Buy
    Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
    Via InvestorPlace
    Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
    The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the... 
    Via Benzinga
    Sunrun Down Over 10% On Silicon Valley Bank Exposure: What Other Companies Are Exposed?
    Shares of Sunrun Inc (NASDAQ: RUN), the largest residential solar developer in the U.S, fell by as much as 15% on Friday as a result of the news that Silicon Valley Bank has been closed by the 
    Via Benzinga
    The Top 7 Growth Stocks in Biotech
    The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.